Instituto Hermes Pardini S.A. (PARD3.SA)


-0.01 (-0.05%)
Symbol PARD3.SA
Price $21.49
Beta 1.155
Volume Avg. 0.39M
Market Cap 2.726B
Shares () -
52 Week Range 0.0-23.67
1y Target Est -
DCF Unlevered PARD3.SA DCF ->
DCF Levered PARD3.SA LDCF ->
Operating Margin -
Debt / Equity -
P/E 14.05 Strong Buy
P/B -


Consensus EPS

Upgrades & Downgrades

Diagnostics & Research
São Paulo

Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. It offers clinical analysis tests, diagnostic imaging, vaccines, check-ups, and other diagnostic services through 124 centers in the states of Minas Gerais, Goiás, São Paulo, and Rio de Janeiro. The company also provides lab-to-lab services, such as specialized tests for other laboratories, as well as consulting, training, and support services for its customers. It primarily operates through eight brands, which include Hermes Pardini, Progenética, Diagnóstika, Biocod, DLE, Labfar, Toxicologia Pardini, and Solução. The company serves hospitals, clinics, laboratories, and other companies in the health care sector. Instituto Hermes Pardini S.A. was founded in 1959 and is headquartered in Belo Horizonte, Brazil.